1. Ferlay J, Soerjomataram I, Ervik M et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwie: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr . Accessed 01 Aug 2017.
2. Bierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. Hoboken: Wiley; 2017.
3. •• Postmus PE, Kerr KM, Oudkerk M et al. Early-stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical practice guidelines. Ann Oncol 2017;28(suppl 4):iv1–21. Current European guidelines for the management of patients with locally advanced non-small-cell lung cancer.
4. Rosen JE, Keshava HB, Yao X, et al. The natural history of operable NSCLC in the National Cancer Database. Ann Thorac Surg. 2016;101:1850–5.
5. • Cortes AA, Urguizu LC, Cubero JH. Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art. Trans Lung Cancer Res 2015;4(2):191–7. Comprehensive overview of current evidence for the use of adjuvant chemotherapy in NSCLC.